Paul Korda . com - The Web Home of Paul Korda, singer, musician & song-writer.

International Entertainment News

Monday, April 10, 2006

Medical Services VScan HIV Test Kit Used During LIVE Test on Television

Medical Services VScan HIV Test Kit Used During LIVE Test on Television

EDMONTON, Alberta, April 10 /PRNewswire-FirstCall/ -- Medical Services International Inc. is pleased to announce that its VScan HIV rapid test kit was tested on "LIVE" television with sensational results. Of the individuals participating in the LIVE testing; 75% were known HIV negatives, and 25% were known HIV positives. The individuals doing the test did not know the status of the test subjects. With the television cameras filming, the status of these individuals was tested by the VScan HIV test kit. The results of the "LIVE" testing showed that the VScan HIV test kit was 100% accurate. This demonstration was to introduce the VScan HIV test kit into the European market and as a start to the process of applying for CE status. The VScan HIV test kit continues to show that it is accurate and easy to use and performs exceptionally in all circumstances.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ .

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially.

Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.

Source: Medical Services International Inc.

CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363

Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/

-------
Profile: intent

0 Comments:

Post a Comment

<< Home